The Food and Drug Administration recently authorized Covid shots, that target the omicron variant, for children as young as 6 months old. Eligibility varies depending on if the children receive Moderna’s or Pfizer’s original vaccines as their primary series.
Nevertheless, The FDA stated that it did not authorize omicron shots for children who already received three doses of Pfizer’s vaccine as the agency is still waiting on data supporting the booster dose. The data is expected in January and the FDA will then analyze it as quickly as possible, it said.
The Centers for Disease Control and Prevention would need to sign off on the vaccine’s distribution before pharmacies and physicians can begin administering them.
According to Dr. Robert Califf, head of the FDA, it is important for people to be on top of their shots this winter as immunity against the virus dwindles.
“As this virus has changed, and immunity from previous COVID-19 vaccination wanes, the more people who keep up to date on COVID-19 vaccinations, the more benefit there will be for individuals, families, and public health by helping prevent severe illnesses, hospitalizations, and deaths,” Califf said in a statement.
The FDA authorized the shots based on adult immune response data for similar vaccines made by Pfizer and Moderna which target the original omicron BA.1 variant. Furthermore, the data is also based on BA.1 clinical trial data as well as previous trials that tested the vaccine as a booster.